Levels of Urinary Matrix Metalloproteinase-9 (MMP-9) and Renal Injuries in Patients with Type 2 Diabetic Nephropathy

Journal of Clinical Laboratory Analysis

Volumn 18, Issue 3, 2004, Pages 206-210

  Tashiro, Kyoichi ^a   Koyanagi, Ichiro ^a   Ohara, Ikko ^a   Ito, Takamichi ^a   Saitoh, Akemi ^a   Horikoshi, Satoshi ^a   Tomino, Yasuhiko ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Diabetic nephropathy; MMP 9; Type IV collagen; Urine

Indexed keywords

COLLAGEN TYPE 4; GELATINASE B; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DIAGNOSTIC VALUE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN URINE LEVEL; UREA NITROGEN BLOOD LEVEL;

ADULT; ALBUMINURIA; BLOOD GLUCOSE; BLOOD UREA NITROGEN; CASE-CONTROL STUDIES; COLLAGEN TYPE IV; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FASTING; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; KIDNEY; MATRIX METALLOPROTEINASE 9;

EID: 2342632543     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcla.20024     Document Type: Article

References (15)

1. Yagame M, Suzuki D, Jinde K, et al. Significance of urinary type IV collagen in patients with diabetic nephropathy using a highly sensitive one-step sandwich enzyme immunoassay. J Clin Lab Anal 1997;11:110-116.
2. Iijima T, Suzuki S, Sekizuka K, et al. Follow-up study on type IV collagen in patients with early diabetic nephropathy. J Clin Lab Anal 1998;12:378-382.
3. Tomino Y, Suzuki S, Azushima C, et al. Asian multicenter trials on urinary type IV collagen in patients with diabetic nephropathy. J Clin Lab Anal 2001;15:188-192.
4. Huang F, Horikoshi S, Kurusu A, et al. Levels of urinary matrix metalloproteinase-2 (MMP-2), MMP-9 in patients with IgA nephropathy. Clin Nephrol 2001;55:E18-E19.
5. Ebihara I, Nakamura T, Shimada N, Koide H. Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin dependent diabetes mellitus. Am J Kid Dis 1998;32:544-550.
6. Diamant M, Hanemaaijer R, Verheijen JH, Smit JW, Radder JK, Lemkes HH. Elevated matrix metalloproteinase-2 and-9 in urine, but not in serum, are markers of type 1 diabetic nephropathy. Diabetic Med 2001;18:423-424.
7. Del Prete D, Anglani F, Forino M, et al. Down-regulation of glomerular matrix metalloprotease-2 gene in human NIDDM. Diabetologia 1997;40:1449-1454.
8. Stage classification of diabetic nephropathy: report of the Ministry of Health and Welfare, Japan (in Japanese); 1991. p 251-256.
9. Fujimoto N, Hosokawa N, Iwata K, Shinya T, Okada Y, Hayakawa T. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 9 (92kDa gelatinase/type IV collagenase) using monoclonal antibodies. Clin Chim Acta 1994;231:79-88.
10. Ohgaku S, Asahi T, Kobayashi M, Obata K. Direct determination of concentrations of urinary type IV collagen in normal and diabetic subjects with a sensitive enzyme immunoassay (EIA). J Jpn Diabetes Soc 1996;39:523-526.
11. Maeda K. Overview of dialysis treatment in Japan. Jpn Soc Diabetes Ther 2000;33:1-27.
12. Akiyama K, Shikata K, Sugimoto H, et al. Changes in serum concentrations of matrix metalloproteinases, tissue inhibitors of metalloproteinases and type IV collagen in patients with various types of glomerulonephritis. Res Commun Mol Pathol Pharmacol 1997;95:115-128.
13. Nakamura T, Ebihara I, Tomino Y, Koide H. Increased mRNA expression of metalloproteinase-9 in peripheral blood monocytes from patients with immunoglobulin A nephropathy. Am J Kidney Dis 1996;28:32-39.
14. Urushihara M, Kagami S, Kuhara T, Tamaki T, Kuroda Y. Glomerular distribution and gelatinolytic activity of matrix metalloproteases in human glomerulonephritis. Nephrol Dial Transplant 2002;17:1189-1196.
15. Singh AK, Mo W, Dunea G, Arruda JA. Effect of glycated proteins on the matrix of glomerular epithelial cells. J Am Soc Nephrol 1998;9:802-810.